Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.
about
Effectiveness of VIA, Pap, and HPV DNA testing in a cervical cancer screening program in a peri-urban community in Andhra Pradesh, IndiaAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancerAmerican Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.Antigen-specific immunotherapy of cervical and ovarian cancerMajor clinical research advances in gynecologic cancer in 2015Using biomarkers as objective standards in the diagnosis of cervical biopsies.Loss of estrogen receptor 1 enhances cervical cancer invasion.A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.Intramuscular therapeutic vaccination targeting HPV16 induces T cell responses that localize in mucosal lesions.Impact of improved classification on the association of human papillomavirus with cervical precancer.Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3Adherence to conservative management recommendations for abnormal pap test results in adolescentsHPV Infection-Associated Cancers: Next-Generation Technology for Diagnosis and TreatmentThe clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologiesConsistent condom use increases the regression rate of cervical intraepithelial neoplasia 2-3.Lower cost strategies for triage of human papillomavirus DNA-positive women.Immune therapy for human papillomaviruses-related cancers.From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice.Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epitheliumDevelopment of therapeutic HPV vaccines.Immunoprevention of human papillomavirus-associated malignanciesA comparison of dacron versus Flocked nylon swabs for anal cytology specimen collection.HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesionsHow will HPV vaccines affect cervical cancer?The clinical meaning of a cervical intraepithelial neoplasia grade 1 biopsy.Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis.A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal AntibodiesDynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories.CIN III lesions and regression: retrospective analysis of 635 cases.TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia IIIHuman papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study.Immunohistochemical detection of human papillomavirus capsid proteins L1 and L2 in squamous intraepithelial lesions: potential utility in diagnosis and management.Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8+ T-cell-Mediated Tumor Control in the Genital TractStudy of 2 years follow-up of referral patients with abnormal Pap smearSix-year regression and progression of cervical lesions of different human papillomavirus viral loads in varied histological diagnoses.Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
P2860
Q21136074-BDC4A34F-E3C8-4813-9D62-348C4AAA5A71Q24607403-D7028C65-A1E8-4759-9DB3-5968CFB7208EQ26828840-50CADA07-57F2-43C5-8AD5-BA022DC421F2Q27488697-1088792D-A4E2-407E-AEDC-5846F4190F71Q28077183-6638CE6E-70FF-4A39-90C3-0816D714A6A9Q30431203-FF5BAA6B-E83E-4E92-974D-94AD2186197DQ33617319-9AACA91C-7B81-4996-AF55-F3B6757FCA93Q33834057-C7A50B62-B393-4AA6-9358-7AF4B86A5F6FQ33862762-D18164C2-7B11-4FD8-A841-8959F9192F1CQ33883581-57268EDA-D0FA-4987-AC65-3FCCBC562B5EQ34033800-A2A66B0A-797B-4201-BB1B-026855B4AA37Q34278466-538A98AF-AA7B-495B-A454-28B94E3A536FQ34290170-69C56D6B-0485-442D-81B3-EDF3E41C1E6CQ34330297-2CE6C6E5-E1B4-4C77-B294-5B22C2E54F9AQ34428131-C21B96D7-5451-4FFB-9D1E-A402A2BC7D6AQ34516596-1A25B62F-B913-44AC-8E16-3249446689EAQ34657561-58E384DF-73D4-4B3B-939C-0B93092A51F2Q34774870-21D236BF-614D-49BB-B32B-6BEFDA696C5CQ34788763-2FB0BEC9-425F-41D7-A1A7-F1BC36EC3E7FQ34953499-3521ED3D-E591-4A48-979F-F28916567467Q35044376-2F0E3B5D-E116-407F-9A33-2CC7474347E5Q35149795-7C667F24-0886-4424-8867-28BCE1D60F75Q35234918-FEB49D62-6BE6-4C33-BD39-9CDF20E0321CQ35235035-9CD89176-8120-434A-A6B2-B079F56E9E93Q35588255-43EE21A5-361F-481D-A698-A6F5F4465C60Q35690978-F8600BD0-3D15-4F7C-9EAB-00F4071BF1B4Q35749285-F29D3E14-420B-499E-820A-C2F4C11FF999Q35773930-23DCD9F6-DFD9-4F15-B138-CA91A7D8B32DQ35774348-CCB4DEAA-001D-431D-9293-D8BA356F76ECQ35847330-43970590-CB38-48EF-AC1E-F059527E3427Q35847665-6668545C-792F-4E84-A0B9-B0847C83AA45Q35929418-27F1AB64-6424-4984-A268-E0371F0B2920Q36052694-E733AF30-203E-49A6-ABFD-7800DDC493AAQ36098816-7CDAEF6E-E957-4E1C-8A00-CDD7755BD737Q36468718-6E06C3D4-6CDB-43B1-9C28-AD2AEA2AB781Q36489840-79D6873E-13D5-4BED-994A-F6BD69B51F70Q36535555-703D2640-E23E-47A8-88A2-DB77A0577363Q36616813-AC830914-2920-4568-B13A-ECE1ED379948Q36794559-1748788A-7EA2-45BE-8A68-78DDDC422DA7Q36794745-5F816942-1EF8-4A10-AB4B-89451FA59AB2
P2860
Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Spontaneous regression of high ...... avirus type and HLA phenotype.
@ast
Spontaneous regression of high ...... avirus type and HLA phenotype.
@en
type
label
Spontaneous regression of high ...... avirus type and HLA phenotype.
@ast
Spontaneous regression of high ...... avirus type and HLA phenotype.
@en
prefLabel
Spontaneous regression of high ...... avirus type and HLA phenotype.
@ast
Spontaneous regression of high ...... avirus type and HLA phenotype.
@en
P2093
P2860
P1476
Spontaneous regression of high ...... avirus type and HLA phenotype.
@en
P2093
Andrea Elko
Barbara Wilgus
Brigitte Ronnett
Chienfu Hung
Cornelia L Trimble
Drew Pardoll
Ellen Pizer
Keerti Shah
Patti Gravitt
Richard Daniel
P2860
P304
P356
10.1158/1078-0432.CCR-04-2599
P407
P577
2005-07-01T00:00:00Z